Kodiak Sciences Inc
KOD7.310USD
+0.660+9.92%
收盤 08/04, 16:00（美東）報價延遲15分鐘
385.62M總市值
虧損本益比TTM
關於 Kodiak Sciences Inc 公司
Kodiak Sciences Inc. 是一家生物製藥公司。該公司開發了一種用於視網膜藥物的新技術平臺，即抗體生物聚合物偶聯物 (ABC) 平臺。其 ABC 平臺利用分子工程將基於蛋白質的療法和基於化學的療法融合在一起。其領先的在研藥物 tarcocimab 是一種新型抗血管內皮生長因子 (anti-VEGF) 抗體生物聚合物偶聯物，正在開發中，用於治療高發性視網膜血管疾病，包括糖尿病性視網膜病變（發達國家工作年齡患者失明的原因）和溼性年齡相關性黃斑變性（老年患者失明的原因）。其第二種在研藥物 KSI-501 是一種雙特異性抗體生物聚合物偶聯物，靶向促炎細胞因子白細胞介素 6 (IL-6) 和 VEGF。該公司還在開發第三種在研藥物 KSI-101，這是一種靶向 IL-6 和 VEGF 的非偶聯雙特異性蛋白。
公司簡介
公司代碼KOD
公司名稱Kodiak Sciences Inc
上市日期Oct 04, 2018
CEODr. Victor Perlroth, M.D.
員工數量109
證券類型Ordinary Share
年結日Oct 04
公司地址1250 Page Mill Road
城市PALO ALTO
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編94304
電話16502810850
網址https://kodiak.com/
公司代碼KOD
上市日期Oct 04, 2018
CEODr. Victor Perlroth, M.D.
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
183.32K
+0.63%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Taiyin Yang, Ph.D.
Dr. Taiyin Yang, Ph.D.
Independent Director
Independent Director
--
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Felix J. Baker, Ph.D.
Dr. Felix J. Baker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Bassil I. Dahiyat, Ph.D.
Dr. Bassil I. Dahiyat, Ph.D.
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
183.32K
+0.63%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Taiyin Yang, Ph.D.
Dr. Taiyin Yang, Ph.D.
Independent Director
Independent Director
--
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Baker Bros. Advisors LP
32.81%
BlackRock Institutional Trust Company, N.A.
5.37%
Perlroth (Victor D)
5.11%
Acadian Asset Management LLC
3.69%
The Vanguard Group, Inc.
3.20%
Other
49.82%
持股股東
持股股東
佔比
Baker Bros. Advisors LP
32.81%
BlackRock Institutional Trust Company, N.A.
5.37%
Perlroth (Victor D)
5.11%
Acadian Asset Management LLC
3.69%
The Vanguard Group, Inc.
3.20%
Other
49.82%
股東類型
持股股東
佔比
Hedge Fund
46.97%
Investment Advisor
18.19%
Investment Advisor/Hedge Fund
13.56%
Individual Investor
5.53%
Research Firm
1.50%
Endowment Fund
1.31%
Pension Fund
0.18%
Venture Capital
0.09%
Bank and Trust
0.07%
Other
12.61%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
273
46.04M
87.25%
-8.22M
2025Q1
302
46.32M
87.78%
-8.84M
2024Q4
308
44.88M
85.29%
-7.98M
2024Q3
318
42.74M
81.24%
-12.36M
2024Q2
326
43.49M
82.78%
-12.58M
2024Q1
345
46.64M
88.83%
-7.18M
2023Q4
377
44.39M
84.60%
-13.12M
2023Q3
391
45.97M
87.64%
-8.18M
2023Q2
401
46.07M
88.00%
-6.85M
2023Q1
414
44.84M
85.66%
-7.92M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Baker Bros. Advisors LP
17.31M
32.81%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.83M
5.37%
-21.30K
-0.75%
Mar 31, 2025
Perlroth (Victor D)
2.70M
5.11%
+527.00K
+24.31%
Mar 31, 2025
Acadian Asset Management LLC
1.95M
3.69%
+413.82K
+27.01%
Mar 31, 2025
The Vanguard Group, Inc.
1.69M
3.2%
+6.61K
+0.39%
Mar 31, 2025
Adage Capital Management, L.P.
1.33M
2.51%
+186.18K
+16.34%
Mar 31, 2025
ICONIQ Capital, LLC
1.27M
2.4%
+249.70K
+24.56%
Mar 31, 2025
TCG Crossover Management, LLC
1.15M
2.17%
--
--
Mar 31, 2025
Point72 Asset Management, L.P.
1.07M
2.03%
+548.67K
+104.76%
Mar 31, 2025
Boxer Capital Management, LLC
1.03M
1.96%
+35.00K
+3.50%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
Fidelity Enhanced Small Cap ETF
0.04%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
Schwab U.S. Small-Cap ETF
0%
Virtus LifeSci Biotech Clinical Trials ETF
0%
ProShares UltraPro Russell2000
0%
Vanguard US Momentum Factor ETF
0%
查看更多
Fidelity Enhanced Small Cap ETF
佔比0.04%
iShares Micro-Cap ETF
佔比0.03%
Avantis US Small Cap Equity ETF
佔比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
iShares Russell 2000 Value ETF
佔比0.01%
Invesco RAFI US 1500 Small-Mid ETF
佔比0.01%
Schwab U.S. Small-Cap ETF
佔比0%
Virtus LifeSci Biotech Clinical Trials ETF
佔比0%
ProShares UltraPro Russell2000
佔比0%
Vanguard US Momentum Factor ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
